tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRPT Stock Latest News

Sarepta Therapeutics Refinances Convertible Senior Notes
Company AnnouncementsSarepta Therapeutics Refinances Convertible Senior Notes
12h ago
8K
SRPT
Wedbush bullish on Sarepta, initiates with an Outperform
PremiumThe Fly
Wedbush bullish on Sarepta, initiates with an Outperform
3d ago
SRPT
Sarepta initiated with an Outperform at Wedbush
PremiumThe Fly
Sarepta initiated with an Outperform at Wedbush
3d ago
SRPT
Sarepta Grants CEO Equity Awards After Eight Years
PremiumCompany Announcements
Sarepta Grants CEO Equity Awards After Eight Years
3d ago
8K
SRPT
Needham starts Solid Biosciences at Buy on opening in DMD market
PremiumThe Fly
Needham starts Solid Biosciences at Buy on opening in DMD market
8d ago
SLDB
SRPT
Sell Rating for Sarepta Therapeutics Due to Risks in ENDEAVOR Study and Expected Share Price Decline
PremiumRatingsSell Rating for Sarepta Therapeutics Due to Risks in ENDEAVOR Study and Expected Share Price Decline
16d ago
SRPT
Sarepta Therapeutics: Hold Rating Amid ENDEAVOR Progress and Short-term Challenges
Premium
Ratings
Sarepta Therapeutics: Hold Rating Amid ENDEAVOR Progress and Short-term Challenges
16d ago
SRPT
Sarepta gets FDA approval to test Elevidys regimen in non-ambulant patients
Premium
The Fly
Sarepta gets FDA approval to test Elevidys regimen in non-ambulant patients
16d ago
SRPT
Cautious Outlook on Sarepta Therapeutics Amid Early-Stage Trials and Financial Commitments
PremiumRatings
Cautious Outlook on Sarepta Therapeutics Amid Early-Stage Trials and Financial Commitments
17d ago
SRPT
Sarepta price target raised to $20 from $18 at Bernstein
PremiumThe Fly
Sarepta price target raised to $20 from $18 at Bernstein
17d ago
SRPT
Sarepta provides update on SRP-1003 study
PremiumThe Fly
Sarepta provides update on SRP-1003 study
17d ago
ARWR
SRPT
Arrowhead earns $200M milestone payment from Sarepta
PremiumThe Fly
Arrowhead earns $200M milestone payment from Sarepta
17d ago
ARWR
SRPT
Citizens JMP healthcare analysts hold an analyst/industry conference
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference
23d ago
BNTC
CRSP
New Sarepta label weakens commercial narrative, says H.C. Wainwright
Premium
The Fly
New Sarepta label weakens commercial narrative, says H.C. Wainwright
25d ago
SRPT
Cautious Hold Rating on Sarepta Therapeutics Amid Elevidys Label Updates and Safety Concerns
Premium
Ratings
Cautious Hold Rating on Sarepta Therapeutics Amid Elevidys Label Updates and Safety Concerns
26d ago
SRPT
Sell Rating for Sarepta Therapeutics Amid Label Changes and Market Challenges
PremiumRatings
Sell Rating for Sarepta Therapeutics Amid Label Changes and Market Challenges
26d ago
SRPT
Sarepta confirms FDA approval of updated Elevidys prescribing information
PremiumThe Fly
Sarepta confirms FDA approval of updated Elevidys prescribing information
27d ago
SRPT
Sarepta up 9% after FDA approves new warning label for Elevidys
PremiumThe Fly
Sarepta up 9% after FDA approves new warning label for Elevidys
27d ago
SRPT
FDA approves new safety warning and revised indication for Sarepta’s Elevidys
PremiumThe Fly
FDA approves new safety warning and revised indication for Sarepta’s Elevidys
27d ago
SRPT
FDA appoints Richard Pazdur as Director of CDER
PremiumThe FlyFDA appoints Richard Pazdur as Director of CDER
1M ago
AZN
BMY
Wave Life Sciences price target lowered to $16 from $18 at Wells Fargo
Premium
The Fly
Wave Life Sciences price target lowered to $16 from $18 at Wells Fargo
1M ago
WVE
SRPT
Sarepta price target lowered to $20 from $22 at Barclays
Premium
The Fly
Sarepta price target lowered to $20 from $22 at Barclays
1M ago
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >